Takeda introduces the In Their Shoes experience to the Middle East in support of the IBD patient community
USA - English
Share this article
DUBAI, UAE, June 9, 2021 /PRNewswire/ Takeda (TSE: 4502) (NYSE: TAK) has introduced the In Their Shoes platform, an award-winning, immersive simulation program to promote greater awareness and empathy for patients with Inflammatory bowel disease (IBD), a condition to describe Crohn s disease and ulcerative colitis, to a group of healthcare providers in the Middle East the first time.
The subscription-based program launched with a two-day simulation where healthcare providers and Takeda employees learned about the condition most effectively and profoundly: by living with it.